A phase II study of oxaliplatin combined with continuous infusion topotecan as chemotherapy for patients with previously treated ovarian cancer.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Oxaliplatin (Primary) ; Topotecan (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 15 May 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov [Parent trial: NCT00313612].
- 11 Jul 2011 Status changed from discontinued to completed as reported by ClinicalTrials.gov [Parent trial: NCT00313612].
- 11 Jul 2011 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov [Parent trial: NCT00313612].